Risk of ovarian cancer in women with first-degree relatives with cancer

References

• Amos CI, Struewing JP. Genetic epidemiology of epithelial ovarian cancer. Cancer. 1993; 71: 566–72
   PubMed Web of Science ®Google Scholar
• Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol. 1998; 105: 493–9
   PubMedGoogle Scholar
• Lynch HT, Guirgis HA, Albert S, Brennan M, Lynch J, Kraft C, et al. Familial association of carcinoma of the breast and ovary. Surg Gynecol Obstet. 1974; 138: 717–24
   PubMedGoogle Scholar
• Kirchhoff T, Satagopan JM, Kauff ND, Huang H, Kolachana P, Palmer C, et al. Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer. J Natl Cancer Inst. 2004; 96: 68–70
   PubMedGoogle Scholar
• Niell BL, Rennert G, Bonner JD, Almog R, Tomsho LP, Gruber SB. BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer. J Natl Cancer Inst. 2004; 96: 15–21
   PubMedGoogle Scholar
• Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997; 336: 1401–8
   PubMed Web of Science ®Google Scholar
• Kirchhoff T, Kauff ND, Mitra N, Nafa K, Huang H, Palmer C, et al. BRCA mutations and risk of prostate cancer in Ashkenazi Jews. Clin Cancer Res. 2004; 10: 2918–21
   PubMed Web of Science ®Google Scholar
• Giusti RM, Rutter JL, Duray PH, Freedman LS, Konichezky M, Fisher-Fischbein J, et al. A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet. 2003; 40: 787–92
   PubMed Web of Science ®Google Scholar
• Ikonen T, Matikainen MP, Syrjakoski K, Mononen N, Koivisto PA, Rokman A, et al. BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland. J Med Genet. 2003; 40: e98
   PubMed Web of Science ®Google Scholar
• Sinclair CS, Berry R, Schaid D, Thibodeau SN, Couch FJ. BRCA1 and BRCA2 have a limited role in familial prostate cancer. Cancer Res. 2000; 60: 1371–5
   PubMed Web of Science ®Google Scholar
• Hamel N, Kotar K, Foulkes WD. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer. BMC Med Genet. 2003; 4: 7
   PubMedGoogle Scholar
• Tung KH, Goodman MT, Wu AH, McDuffie K, Wilkens LR, Nomura AM, et al. Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives. Am J Epidemiol. 2004; 159: 750–8
   PubMed Web of Science ®Google Scholar
• Negri E, Pelucchi C, Franceschi S, Montella M, Conti E, Dal ML, et al. Family history of cancer and risk of ovarian cancer. Eur J Cancer. 2003; 39: 505–10
   PubMed Web of Science ®Google Scholar
• Auranen A, Pukkala E, Makinen J, Sankila R, Grenman S, Salmi T. Cancer incidence in the first-degree relatives of ovarian cancer patients. Br J Cancer. 1996; 74: 280–4
   PubMed Web of Science ®Google Scholar
• Lorenzo BJ, Rawal R, Hemminki K. Familial association of specific histologic types of ovarian malignancy with other malignancies. Cancer. 2004; 100: 1507–14
   PubMed Web of Science ®Google Scholar
• Kerber RA, Slattery ML. The impact of family history on ovarian cancer risk. The Utah Population Database. Arch Intern Med. 1995; 155: 905–12
   PubMedGoogle Scholar
• Purdie D, Green A, Bain C, Siskind V, Ward B, Hacker N, et al. Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. Int J Cancer. 1995; 62: 678–84
   PubMed Web of Science ®Google Scholar
• Soegaard M, Jensen A, Frederiksen K, Høgdall E, Høgdall C, Blaakær J, et al. Accuracy of self-reported family history of cancer in a large case-control study of ovarian cancer. Cancer Causes Control. 2008; 19: 469–79
   PubMed Web of Science ®Google Scholar
• Glud E, Kjaer SK, Thomsen BL, Hogdall C, Christensen L, Hogdall E, et al. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Arch Intern Med. 2004; 164: 2253–9
   PubMed Web of Science ®Google Scholar
• Osterlind A, Jensen OM. Evaluation of cancer registration in Denmark in 1977. Preliminary evaluation of cancer registration by the Cancer Register and the National Patient Register. Ugeskr Laeger. 1985; 147: 2483–8
   PubMedGoogle Scholar
• Storm HH. Completeness of cancer registration in Denmark 1943–1966 and efficacy of record linkage procedures. Int J Epidemiol. 1988; 17: 44–9
   PubMed Web of Science ®Google Scholar
• Soegaard M, Jensen A, Hogdall E, Christensen L, Hogdall C, Blaakaer J, et al. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA Study. Cancer Epidemiol Biomarkers Prev. 2007; 16: 1160–6
   PubMed Web of Science ®Google Scholar
• Walker GR, Schlesselman JJ, Ness RB. Family history of cancer, oral contraceptive use, and ovarian cancer risk. Am J Obstet Gynecol. 2002; 186: 8–14
   PubMed Web of Science ®Google Scholar
• Schildkraut JM, Thompson WD. Relationship of epithelial ovarian cancer to other malignancies within families. Genet Epidemiol. 1988; 5: 355–67
   PubMed Web of Science ®Google Scholar
• Parazzini F, Negri E, La VC, Restelli C, Franceschi S. Family history of reproductive cancers and ovarian cancer risk: an Italian case-control study. Am J Epidemiol. 1992; 135: 35–40
   PubMed Web of Science ®Google Scholar
• Boyd J, Rubin SC. Hereditary ovarian cancer: molecular genetics and clinical implications. Gynecol Oncol. 1997; 64: 196–206
   PubMed Web of Science ®Google Scholar
• Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet. 2001; 68: 700–10
   PubMed Web of Science ®Google Scholar
• Rader JS, Neuman RJ, Brady J, Babb S, Temple S, Kost E, et al. Cancer among first-degree relatives of probands with invasive and borderline ovarian cancer. Obstet Gynecol. 1998; 92: 589–95
   PubMed Web of Science ®Google Scholar
• Purdie DM, Siskind V, Bain CJ, Webb PM, Green AC. Reproduction-related risk factors for mucinous and nonmucinous epithelial ovarian cancer. Am J Epidemiol. 2001; 153: 860–4
   PubMed Web of Science ®Google Scholar
• Kurian AW, Balise RR, McGuire V, Whittemore AS. Histologic types of epithelial ovarian cancer: have they different risk factors?. Gynecol Oncol. 2005; 96: 520–30
   PubMed Web of Science ®Google Scholar